F
Francesca Poggio
Researcher at University of Genoa
Publications - 77
Citations - 2085
Francesca Poggio is an academic researcher from University of Genoa. The author has contributed to research in topics: Breast cancer & Fertility preservation. The author has an hindex of 19, co-authored 77 publications receiving 1484 citations. Previous affiliations of Francesca Poggio include Université libre de Bruxelles.
Papers
More filters
Journal ArticleDOI
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: A systematic review and meta-analysis
Francesca Poggio,Francesca Poggio,Marco Bruzzone,Marcello Ceppi,Noam Pondé,G. La Valle,L. Del Mastro,E. de Azambuja,Matteo Lambertini +8 more
TL;DR: In TNBC patients, platinum-based neoadjuvant chemotherapy is associated with significantly increased pCR rates at the cost of worse hematological toxicities, with no increased risk of grade 3 and 4 neuropathy.
Journal ArticleDOI
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient–Level Data
Matteo Lambertini,Halle C. F. Moore,Robert C. F. Leonard,Sibylle Loibl,Pamela N. Munster,Marco Bruzzone,Luca Boni,Joseph M. Unger,Richard A. Anderson,Keyur Mehta,Susan Minton,Francesca Poggio,Kathy S. Albain,Douglas Adamson,Bernd Gerber,Amy Cripps,Gianfilippo Bertelli,Sabine Seiler,Marcello Ceppi,Ann H. Partridge,Lucia Del Mastro +20 more
TL;DR: Evidence is provided for the efficacy and safety of temporary ovarian suppression with GnRHa during chemotherapy as an available option to reduce the likelihood of chemotherapy-induced POI and potentially improve future fertility in premenopausal patients with early breast cancer.
Journal ArticleDOI
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
Matteo Lambertini,Marcello Ceppi,Francesca Poggio,Fedro A. Peccatori,Hatem A. Azim,Donatella Ugolini,Paolo Pronzato,Sibylle Loibl,Halle C. F. Moore,Ann H. Partridge,Paolo Bruzzi,L. Del Mastro +11 more
TL;DR: Temporary ovarian suppression with LHRHa in young breast cancer patients is associated with a reduced risk of chemotherapy-induced POF and seems to increase the pregnancy rate, without an apparent negative consequence on prognosis.
Journal ArticleDOI
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial
Matteo Lambertini,Luca Boni,Andrea Michelotti,Teresa Gamucci,Tiziana Scotto,Stefania Gori,Monica Giordano,Ornella Garrone,Alessia Levaggi,Francesca Poggio,S. Giraudi,Claudia Bighin,C. Vecchio,Mario Roberto Sertoli,Paolo Pronzato,Lucia Del Mastro +15 more
TL;DR: Among premenopausal women with either hormones receptor-positive or hormone receptor-negative breast cancer, concurrent administration of triptorelin and chemotherapy, compared with chemotherapy alone, was associated with higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate.
Journal ArticleDOI
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
Lucia Del Mastro,Marcello Ceppi,Francesca Poggio,Claudia Bighin,Fedro A. Peccatori,Isabelle Demeestere,Alessia Levaggi,S. Giraudi,Matteo Lambertini,Alessia D'Alonzo,Giuseppe Canavese,Paolo Pronzato,Paolo Bruzzi +12 more
TL;DR: A systematic review and meta-analysis of randomized trials evaluating the efficacy of GnRHa, given before and during chemotherapy, in the prevention of POF in premenopausal cancer patients shows that the temporary ovarian suppression induced by GnR Ha significantly reduces the risk of chemotherapy-induced POFIn young cancer patients.